PacBio completes asset sale to Illumina for undisclosed sum.

lunes, 2 de febrero de 2026, 9:32 am ET1 min de lectura
ILMN--
PACB--

• PacBio completes asset sale to Illumina Cambridge Limited. • Assets related to short-read DNA sequencing technology acquired. • Buyer pays consideration for the asset sale. • Company to focus on long-read sequencing technology.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios